Welcome to Delicate template
Header
Just another WordPress site
Header
Just another WordPress site
Header
Just another WordPress site
Header
Just another WordPress site
Header

Botulax

April 25th, 2012 | Posted by admin in Featured Products

Botulax

What is Botulax? Botulax contains 100 units (U) of Clostridium botulinum toxin type A, 0.5 milligrams of albumin (human)and 0.9 milligrams of sodium chloride in a sterile, vacuum-dried from without a preservative. Botulinum toxin type A neutroxin: purified from Clostridium botulinum type A Albumin: Human serum albumin,bulking and stabilizing agent and adhesion reducer. KP grade NaCl: Bulking agent and keeping isotonicity during formulation KP grade Developmental status: 2007.5: reported nonclinical study 2008.3: reported clinically study Phase l 2009.7: Finished Phase lll clinically study Characteristics of Botulax:Higher specific activity than those of other company’s botolinum toxin products by improving lyophilization process Facility: GMP approved by KFDA

Composition
Each vial contains:

Active ingredient: Clostridium botulinum toxins type A (100 units).
Stabilizer: Human serum albumin 0.5mg
Tonic Adjuster: Sodium chloride (KP) 0.9mg

Description:
It appears a a lyophilized white powder for injection in a colorless transparent vial

Mode of action

Botulinum Toxin Type A blocks signals from the nerves to the muscles.
The injected muscle can no longer contract, which causes the wrinkles to relax and soften.
It is most often used on forehead lines, crow’s feet (lines around the eye) and frown lines.
Features and Benefits

Botulax guarantees high patient satisfaction.
Potency variation is strictly controlled to within 91-115 units/ vial, more stringent than the legally required range.
Size of toxin complex is 900kDa, minimize spread of botulinum toxin outside of the injection site.
Such large and homogeneous size of the toxin complex ensures precise and uniform effect at the time of injection, guaranteeing high patient satisfaction with Botulax
Botulax is providing more choices.
Botulax was launched in the market as a 100unit product. Development of 25, 50,and 200-unit products are underway, “one vial for one patient”injection will be realized soon to minimized the risk of secondary infection

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply